Appeals court rules abortion pill can remain on market with restrictions
But the 5th U.S. Circuit Court of Appeals also ruled it was unlawful for the FDA to allow mifepristone to be taken later in pregnancy, be mailed directly to patients and be prescribed by a medical professional other than a doctor. Full Story
/https://static.texastribune.org/media/files/cfd61cdf4fe36c2a220289d573376697/0415%20Abortion%20Pill%20Protest%20SH%20TT%2017.jpg)